Juvena Therapeutics | $33,500,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
Allos | $5,000,000 | (Jan 14, 2026)
Certified by Founder
Lodge
causaLens
start up
United Kingdom
- London, England
- 28/01/2022
- Series A
- $45,000,000
causaLens are the pioneers of Causal AI — a giant leap in machine intelligence.
We build Causal AI-powered products that are trusted by leading organizations across a wide range of industries. Our No-Code Causal AI Platform empowers all types of users to make superior decisions through an intuitive user interface. We are creating a world in which humans can trust machines with the greatest challenges in the economy, society and healthcare.
For more information visit www.causaLens.com or contact us on info@causaLens.com.
- Industry Software Development
- Website https://www.causalens.com/
- LinkedIn https://www.linkedin.com/company/causalens/
Related People
Darko Matovski, PhDCo Founder
United Kingdom -
London, England
We are creating a world in which humans can trust machines with the greatest challenges in the economy, society and healthcare.
PayMedix | $33,000,000 | (Jan 14, 2026)
WeatherPromise | $12,800,000 | (Jan 14, 2026)
Diffraqtion | $4,200,000 | (Jan 14, 2026)
WithCoverage | $42,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Cloudforce | $10,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)